
The Securities and Exchange Board of India (Sebi) on Wednesday, 14 October 2026, confirmed its interim directions against Rajesh Exports and its chairman Rajesh Mehta, citing pending concerns over financial disclosures, consolidation of overseas subsidiaries and alleged routing of funds through related parties. Mehta will continue to be barred from dealing in the company’s securities until further orders.
The regulator flagged a disparity between the company’s consolidated revenue of Rs 15.45 trillion and Valcambi SA’s standalone revenue of Rs 3,027.38 crore for FY21 to FY25, calling it about 99 per cent. Livemint reported that Sebi alleged about Rs 15.15 trillion, or 99.8% of subsidiary revenue, was misrepresented. Business Standard noted Sebi questioned a document submitted by the company, whose authenticity Mehta’s brother reportedly denied signing.
The regulator directed a newly appointed forensic auditor to complete its work expeditiously and asked the investigating authority to conclude its probe without delay, according to Livemint. The directions will remain in force until further orders. NDTV Profit reported that Mehta expressed confidence of being cleared.
The three outlets report the same confirmatory order with near-uniform facts, each drawing on the Sebi document directly. Business Standard leads with the regulator’s own phrasing about incomplete information, Livemint foregrounds the revenue-mismatch figure and the forensic audit directive, and NDTV Profit adds Mehta’s personal assurance of clearance. None carries an editorial slant, all three treat the order as a factual regulatory update. The key open item is the forensic auditor’s timeline and the probe’s conclusion, both of which Sebi has asked to be expedited without setting a deadline.
Coverage: 3 sources, 3 neutral
Sources (3): business-standard.com (neutral report), ndtvprofit.com (neutral report), livemint.com (neutral report)
This brief was synthesised by AI from the 3 sources linked above, so one read covers every framing they carry. Methodology and corrections.